Home/Medmain/Atsushi Murakami
AM

Atsushi Murakami

Board of Director

Medmain

Therapeutic Areas

Medmain Pipeline

DrugIndicationPhase
PidPort AI AnalysisPathological screening of tissue and cellsCommercial
Ki-67 Labeling Index AIAssessment in immunohistochemical specimensResearch/Development